Introduction
Various methods for the measurement of tricyclic antidepressant drugs have been described since 1960. An outline of the chemical structure of the tricyclics and related drugs is shown in Figure 1 . Common to the majority of methods is the need for extraction of the drug from the biological medium before analysis. This usually involves extraction of an alkaline medium with an organic solvent. The extract is then assayed by spectrofluorimetry, isotope-derivative dilution analysis, gas-liquid chromatography (GC),2 "high-performance" liquid chromatography (HPLC), or radioimmunoassay, to name the most commonly used techniques.
The first studies requiring the measurement of tricyclic antidepressants were concerned with the metabolism, distribution, and excretion of AT, NT, IMI, or DM1. The assay was usually by spectrophotometry or simple chemical analyses, some of which involved separation of parent drug from its metabolites by chromatography (1-9). None of these assays were sensitive enough for analysis of amounts of drugs likely to be in plasma or blood. Fluorimetric techniques were developed that had adequate sensitivity but were usually nonspecific because of metabolite interference (10-12).
More suitable assays were developed in 1967, first by Moody and colleagues (13), who described a more advanced fluorimetric procedure for IMI and DM1, and then by Hammer and Brodie (14) , who developed an isotope-derivative assay for NT or DM1. A further advance came h 1970-71 with the first suitable GC techniques for DM1, NT, and [15] [16] [17] [18] .
Since then, the majority of published methods have involved GC, at first with the more conventional detectors, flame-ionization or electron-capture, but more recently with either nitrogen-specific detection or mass-fragmentography. Other contemporary methods investigated include thin-layer chromatography-densitometry (TLC-D), HPLC, and radioimmunoassay.
In this review, we will discuss the approaches used since 1967, emphasizing specificity, sensitivity, accuracy, precision (reproducibility), expense, convenience, and ease of sample processing. A procedure will be considered specific if drug metabolites do not interfere and if only drugs that have been shown not to interfere with the assay procedure are administered concomitantly. The sensitivity required for the routine analysis of plasma amounts of most tricyclic drugs is apDepartment of Psychiatry and 1 Howard Florey Institute of Experimental Physiology and Medicine, University of Melbourne, Parkville, Australia, 3052.
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proximately 5-10 Lg/L. The assay should be capable of a precision of approximately ±5-10% (CV) over the total concentration range required. A "rapid" assay is one in which an answer can be given within 24 h of receipt of a sample.
Collection and Storage of Samples
Blood is usually collected into heparinized glass or polystyrene tubes; centrifuged as soon as possible, at least within 24 h (19); and the plasma stored frozen. Plasma may be left for several days at room temperature without change in amounts of tricyclics (19) or, when stored frozen, for at least 120 days (20) .
A recent practice has been to collect blood samples into Vacutainer Tubes (Becton, Dickinson & Co.). It has now been shown that this procedure results in lower plasma values for tricyclics when compared with blood storage in conventional glass or polystyrene tubes (21). After only 5 mm storage in Vacutainer Tubes, a 33% reduction in IMI concentration has been observed. The reason for this reduction is that the plasticizer, tris (2-butoxyethyl) phosphate, elutes from the rubber stoppers of the Vacutainer Tubes and inhibits protein binding of the drug (22). The plasticizer selectively affects the binding of IMI to a1-acid glycoprotein but does not change IMI binding to albumin and lipoproteins (22). The change in protein binding leads to a redistribution between plasma and erythrocytes, decreasing drug amounts in plasma. Vacutainer Tubes have been found to vary considerably with respect to the amount of inhibition of protein binding (22), and are thus not satisfactory for collection of blood samples for quantitating these drugs. Careful consideration should be given to collection and storage of samples for newer drugs on which little information is available.
Another commonly used practice for multiple blood sampling is the use of an indwelling needle or cannula, which is flushed with heparinized saline to prevent clotting. A recent study (23) showed that only 50 mt.units of heparin caused the unbound percentage of propanolol to increase from 9.9 to 13.4%. This increase was significantly correlated with an increase in free fatty acids, which results from the heparininduced increase in lipoprotein lipase activity. Because the tricyclic antidepressants also bind strongly to lipoproteins (22, 24), heparin-induced increases in the breakdown of lipoproteins may lead to increased amounts of unbound drug. This also could lead to a redistribution of the drug and result in low measurements in plasma because of the greater proportion distributed to the erythrocytes. Many pharmacokinetic studies of the tricyclic antidepressants have involved indwelling heparin locks and measurement of drugs in plasma rather than in whole blood; however, the conclusions of such studies should be considered subject to doubt, until the effect of heparin on protein-binding and distribution of the tricyclic antidepressants has been more thoroughly studied. A further problem is introduced by recent findings suggesting that the ratio of erythrocyte to plasma drug content for the tricyclic antidepressants is not constant between individuals (25; and our own studies, manuscript in preparation). If this ratio is not constant, whole blood rather than plasma should be used for pharmacokinetic studies. De- the method used with regard to recovery, specificity, and nature of the "blank."
Extraction of Plasma Samples
The tricyclic drugs are lipophilic strong bases; thus at high pH (approximately 10), the free base can be extracted from the aqueous phase into an organic solvent such as n -heptane, n-hexane, diethyl ether, or petroleum ether, and at pH <3, the base can be re-extracted into the aqueous phase. The partition of IMI and its metabolites between aqueous solutions of various pH and organic solvents has been comprehensively evaluated by Weder and Bickel (26) . A similar partition pattern is observed for the other tricyclics (27, 28 
Isotope-Derivative Dilution Analysis
In this procedure, the compound to be determined is reacted quantitatively with a radioactive reagent of known specific activity. The radioactive product is then separated and purified. The amount of activity in the pure product indicates the amount of radioactive reagent it contains; thus, from the stoichiometry of the reaction, the amount of compound present can be calculated.
In 1967 Hammer and Brodie (14) described an isotopederivative dilution procedure for the measurement of the secondary-amine tricyclics, DM1 and NT. The method involved a one-step extraction followed by formation of a derivative with 13H]acetic anhydride. The labeled acetyl-derivative was extracted into heptane and assayed by liquid scintillation spectrometry.
The sensitivity of the method is 5 ig/L and, until recently, this has been the most widely used of all published methods.
The major drawback to the method is its lack of specificity. Any secondary or primary amine could undergo the chemical reaction involved, with the result that the hydroxylated and demethylated metabolites of the drugs could interfere. Incorporation of a chromatographic separation step has overcome this problem (20, 27, 28, 36) .
Some methods (20, 28, 29) incorporated a second isotope to correct for procedural losses. Synthesis of '4C-labeled tncyclic drugs with high specific activity has allowed the development of these double-isotope derivative dilution assays.
This technique is sensitive, specific, precise, rapid, and relatively inexpensive, if one has access to a liquid scintillation spectrometer. An interlaboratory comparison of NT standards and plasma samples assayed by both GC and double-isotope dilution has validated the specificity of this methodological approach (37). Similarly, there has been close agreement when the same samples are assayed by radioimmunoassay
(38).
This approach is particularly suitable for measurement of the secondary-amine tricyclic drugs. An isotope-derivative assay for tertiary amines in which [t4Clmethyl iodide was used for derivatization of JMI was described in 1970 (39). In a more recent approach (28), CMI was converted to its carbamate with trichloroethylchloroformate, which on hydrolysis yielded DCMI. Because many steps were involved, yields of the labeled-derivative were low (4-6%), making the procedure unsuitable for routine use. "In vitro" demethylation of AT by rat liver homogenates before acetylation has been attempted, but also has poor yields
(40).
In both the method described by Riess (27) and that by Carnis and colleagues (28) '4C-tracer with low specific activity and [3H]acetic anhydride with relatively low specific activity are used. Considering the very large mass of '4C-tracer added to each sample, it is surprising 
Gas-Liquid Chromatography
GC is now the most widely used approach for the measurement of the tricyclic drugs. Initial studies involved flame-ionization detection or electron-capture detection; however, the development of the alkali flame-ionization detector, which is selective to nitrogen, and the coupling of GC with mass fragmentography (GC-MF) have led to these becoming the most widespread methods currently in use for the complete range of tricyclic drugs.
Flame-ionization detection.
Weder Single oral doses in patients use of tnichloroethylchloroformate. The latter con,ersion could also be applied to NT; hence, by prior separation on the column, AT and NT could be determined.
The sensitivity was 1 4ug/L, and measurements were free from metabolite interference. The column extraction seemed quicker than the conventional three-step technique; thus, this method appears to have great potential. ). This detector is more sensitive than a flame-ionization detector to the tricyclic compounds, which has led to the development of assay techniques based on those previously described for flame-ionization detection. The nitrogen-sensitive detector allows reliable estimation of concentrations as low as 5 g/L in plasma samples of 2-3 mL.
Most of the published methods involve a three-step extraction, but others (60-64) find that only a single extraction is necessary. Similarly, some investigators find that derivatization of secondary amines is necessary (61, 64-68 
Thin-Layer Chromatography-Densitometry
A simple procedure for the measurement of IMI and DM1 based on TLC was described in 1973 (94). After a one-step extraction, TLC in one dimension separated IMI and its metabolites.
After the drugs were reacted with nitrous gases to produce an intense yellow, the results were measured densitometrically. The sensitivity of the technique was 5 zg/L with 5-mL plasma samples. A similar technique for the measurement of AT and NT was developed by Faber and coworkers (95). Breyer and Villmusen A similar assay with even greater sensitivity (0.5 ftg/L) has been described for AT and NT (98).
"High-Performance" Liquid Chromatography
The application of high-speed ion.pair partition and liquid-solid adsorption chromatography to the separation of tricyclic drugs was first described in 1975 (99, 100).
Since is to be used, one may observe isotopic effects on the column, with separation of the deuterated form from the unlabeled drug (121).
Overall, most methods describing the use of HPLC appear to have adequate sensitivity, specificity, accuracy, and precision for the measurement of steady-state plasma samples from patients; however, few studies have been made with actual patient's samples. One important aspect of specificity-interference from structurally related psychotropic drugs-has recently been assessed in detail (31). Comparison of results from HPLC with those of other techniques on the same plasma samples is also important (104, 110, 114) .
The technique will probably gain in popularity and, if used with mass fragmentography, will be a powerful and useful procedure for measuring plasma concentrations of drugs and their metabolites.
Radioimmunoassay
Although radioimmunoassay has been widely used for measurement of many drugs, peptides, proteins, and steroid hormones, only recently has it been used for psychotropic drugs. The first report was by Spector and colleagues in 1975, who described a method for IMI (122) . Since then, 10 other methods have been described. A summary of the published Table 5 . A screening method for tricyclics in urine has also been reported. Antisera have been prepared by injection of a variety of tricyclic drugs, coupled to bovine serum albumin, into rabbits or sheep. Derivatization of the parent tricyclic drug has primarily involved modification of the side chain to form N-4-bromobutyl-NT (123) , N-4-succinyl-NT (or -DM1) (32, 33, 124) , N-3-carboxypropionyl-NT (-DM1), N-2-carboxyethyl-NT (-DM1) (125) , or N-8-succinyl-NOMI (126) . Coupling through the ring structure by using 10-or 11 -hydroxy-CMI to prepare 10-(11-)hemisuccinate-CMI has been described by Read and colleagues (127, 128) . Complete details of the chemistry of some of these reactions were described by Hubbard and coworkers (125) .
The extent of incorporation of the hapten into bovine albumin has been variable (33, 123, 125, 126) , and although many of the hapten-carrier protein complexes have been less than ideal (129), satisfactory antisera have been produced.
Many antisera show substantial cross reactivity between the secondary and tertiary structures, as well as to other tncyclic drugs with similar ring structures (38) . Major changes in the tricyclic nucleus, e.g., a change from a seven-membered to a six-membered ring, decrease binding. Those with only two rings showed no cross reactivity; this result would be expected if coupling occurred on the side chain. There is substantial evidence, however, based on Scatchard plot analysis of the Guildford antiserum (123) , to show that the side-chain structure is also an important antigenic determinant (38). Most antisera also show little or no cross reactivity to the 2-or lO-hydroxy metabolites (32, 33, 38) or to other common psychotropic drugs (38). The described radioimmunoassays are sensitive (<2 zg/L) and enable rapid analysis of small volumes of plasma (<0.5 mL). The Guildford antiserum (123) can be used as a direct assay without extraction (38, 130, 131) . This is also true of the radioimmunoassay for NOMI (126) . Where extraction is required, either petroleum ether or n-heptane has been used.
The precision of the various radioimmunoassays is adequate for routine clinical plasma measurements.
The specificity of 131, 134, 135) . The major problem of specificity has been the cross reactivity of the tertiary amines for antisera raised against a secondary amine. Further, for many of the antisera the cross reactivities of the secondary and tertiary amines are not identical (123) , so that it is not possible to accurately measure either AT or AT plus NT in patients receiving the tertiary amine (130) . By changing the pH of the incubation mixture, similar cross reactivities were obtained for AT and NT; hence, total amounts could be measured (131) . Lucek and Dixon (32) described a method of selective extraction of AT and NT based on changes in the pH of the plasma. A novel approach described by Brunswick and colleagues (33, 135) enables the separation of IMI from DM1 during extraction:
succinyl-DMI is formed in the heptane extract of plasma; after acidification, IMI partitions into the acid layer and the succinyl-DMI remains in the basic layer.
One of the major problems limiting the development of radioimmunoassay has been the unavailability of tnitiated tracers with high specific activity. As showi by Aherne these results show that these radioimmunoassays must be used cautiously to measure total amounts of tnicyclics. Although at the present time radioimmunoassays for this class of psychotropic drugs are not widely used, this situation will change with the increasing availability of suitable antisera. However, the specificity and other characteristics of all antisera are different, and each new assay must be rigorously checked against a more definitive method. This is particularly important if commercial kit assays are used for clinical studies.
As a summary, Table 6 presents in simplified form a comparison of some of the practical aspects of each of the different types of contemporary analytical techniques for the measurement of plasma amounts of tnicyclic antidepressant drugs. The methods of choice for routine plasma measurements are GC, double-isotope-derivative dilution, HPLC, and radioimmunoassay.
The highly specific technique of GC-MF has an important role in definitive studies involved with the characterization of metabolites and drug phanmacokinetics. The high cost of the instrumentation, however, will prevent this technique from becoming widely used for routine analysis. The technique with the most potential is immunoassay, which is simple, inexpensive, and rapid, and can potentially be automated.
The future development of further antisera-specific for bicyclic, tricyclic, on tetracyclic drugs-and the recently developed enzyme immunoassays (138) will undoubtedly lead to immunoassay as the method of choice for routine analysis.
We will describe the application of these methods for pharmacokinetic and clinical studies in a further review now in preparation.
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